Ivan Bergstein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ivan Bergstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ivan Bergstein. Ivan Bergstein is Chief Executive Officer in STEMLINE THERAPEUTICS INC ($STML).
Latest Insider Trading Transactions of Ivan Bergstein
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 4.12 | 356,700 | 1,469,604 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 3.30 | 180,704 | 596,323 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | D | 2.92 | 90,352 | 263,828 | 0 | |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | U | 0.00 | 3,024,336 | 0 | 0 | 3 M to 0 (-100.00 %) |
| Jun 10 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 220,000 | 0 | 3,024,336 | 2.8 M to 3 M (+7.84 %) |
| Apr 20 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 4.88 | 53,618 | 261,656 | 2,804,336 | 2.9 M to 2.8 M (-1.88 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 4.92 | 36,542 | 179,787 | 2,857,954 | 2.9 M to 2.9 M (-1.26 %) |
| Mar 13 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 5.09 | 20,909 | 106,427 | 2,894,496 | 2.9 M to 2.9 M (-0.72 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 28 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 24,642 | 158,202 | 2,915,405 | 2.9 M to 2.9 M (-0.84 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |
| Feb 14 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 425,274 | 0 | 2,940,047 | 2.5 M to 2.9 M (+16.91 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.48 | 2,446 | 25,634 | 2,514,773 | 2.5 M to 2.5 M (-0.10 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.75 | 18,744 | 201,498 | 2,517,219 | 2.5 M to 2.5 M (-0.74 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.97 | 29,613 | 324,855 | 2,535,963 | 2.6 M to 2.5 M (-1.15 %) |
| Jan 03 2020 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.58 | 5,225 | 55,281 | 2,565,576 | 2.6 M to 2.6 M (-0.20 %) |
| Aug 16 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 14.73 | 35,010 | 515,697 | 2,570,801 | 2.6 M to 2.6 M (-1.34 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 14.77 | 16,994 | 251,001 | 2,605,811 | 2.6 M to 2.6 M (-0.65 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 15.10 | 28,500 | 430,350 | 2,622,805 | 2.7 M to 2.6 M (-1.07 %) |
| Jun 28 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 15.49 | 10,822 | 167,633 | 2,651,305 | 2.7 M to 2.7 M (-0.41 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.05 | 2,151 | 23,769 | 2,662,127 | 2.7 M to 2.7 M (-0.08 %) |
| Mar 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.11 | 55,073 | 611,861 | 2,664,278 | 2.7 M to 2.7 M (-2.03 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.41 | 6,800 | 77,588 | 2,719,351 | 2.7 M to 2.7 M (-0.25 %) |
| Mar 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 11.41 | 6,800 | 77,588 | 2,719,351 | 2.7 M to 2.7 M (-0.25 %) |
| Feb 27 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 12.03 | 22,905 | 275,547 | 2,726,151 | 2.7 M to 2.7 M (-0.83 %) |
| Feb 15 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 10.98 | 34,132 | 374,769 | 2,749,056 | 2.8 M to 2.7 M (-1.23 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 17,009 | 0 | 2,783,188 | 2.8 M to 2.8 M (+0.61 %) |
| Feb 08 2019 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 284,748 | 0 | 2,766,179 | 2.5 M to 2.8 M (+11.48 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 200,000 | 0 | 2,481,431 | 2.3 M to 2.5 M (+8.77 %) |
| Sep 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 125,000 | 0 | 2,281,431 | 2.2 M to 2.3 M (+5.80 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 18.17 | 6,117 | 111,146 | 2,156,431 | 2.2 M to 2.2 M (-0.28 %) |
| Mar 14 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.18 | 31,740 | 545,293 | 2,162,548 | 2.2 M to 2.2 M (-1.45 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 143,708 | 0 | 2,194,288 | 2.1 M to 2.2 M (+7.01 %) |
| Mar 09 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 16.56 | 6,797 | 112,558 | 2,050,580 | 2.1 M to 2.1 M (-0.33 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.26 | 13,407 | 231,405 | 2,057,377 | 2.1 M to 2.1 M (-0.65 %) |
| Feb 28 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 17.61 | 10,776 | 189,765 | 2,070,784 | 2.1 M to 2.1 M (-0.52 %) |
| Feb 16 2018 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 15.80 | 3,820 | 60,356 | 2,081,560 | 2.1 M to 2.1 M (-0.18 %) |
| Mar 09 2017 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 266,285 | 0 | 2,085,380 | 1.8 M to 2.1 M (+14.64 %) |
| Mar 09 2017 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 8.13 | 5,401 | 43,910 | 1,819,095 | 1.8 M to 1.8 M (-0.30 %) |
| Mar 01 2017 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 7.01 | 10,480 | 73,465 | 1,824,496 | 1.8 M to 1.8 M (-0.57 %) |
| Mar 01 2017 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.97 | 7,500 | 52,275 | 1,834,976 | 1.8 M to 1.8 M (-0.41 %) |
| Feb 17 2017 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 6.42 | 3,652 | 23,446 | 1,842,476 | 1.8 M to 1.8 M (-0.20 %) |
| Mar 10 2016 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 5.34 | 5,537 | 29,568 | 1,846,128 | 1.9 M to 1.8 M (-0.30 %) |
| Feb 26 2016 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | A | 4.12 | 356,700 | 1,469,604 | 356,700 | |
| Feb 26 2016 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 178,083 | 0 | 1,851,665 | 1.7 M to 1.9 M (+10.64 %) |
| Feb 19 2016 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 4.46 | 3,244 | 14,468 | 1,673,582 | 1.7 M to 1.7 M (-0.19 %) |
| Dec 31 2015 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Gift | G | 0.00 | 250,000 | 0 | 1,676,826 | 1.9 M to 1.7 M (-12.97 %) |
| Dec 01 2015 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Sell | S | 8.20 | 12,235 | 100,327 | 1,926,826 | 1.9 M to 1.9 M (-0.63 %) |
| Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Option Exercise | A | 15.75 | 142,668 | 2,247,021 | 142,668 | |
| Mar 10 2015 | STML | STEMLINE THERAPEUT ... | Bergstein Ivan | Chief Executive Off ... | Grant | A | 0.00 | 50,260 | 0 | 1,939,061 | 1.9 M to 1.9 M (+2.66 %) |
Page: 1